Reliable Partnerships for Hit-to-Lead and Lead-Optimization Programs

Characterization of your compounds in one or more of our assays (cAMP, IP-One, Aequorin, GTPS, ERK1/2, Radioligand Binding assay, Beta-Arrestin, or customized assays) to determine agonist, antagonist or allosteric modulator potency, efficacy and functional selectivity with your data returned five days after compound delivery for repetitive testing.